knowledge -WSS

knowledge

author：focus 2025-09-30 18:54:32 - browse：93

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Doctors' information doesn't help them choose wisely when sick

leisure time

WSS

Timeline: Key moments in fight for gay rights

What we’ve learned from the Aduhelm mess

'Revelatory' study finds a smoking impact that remains after quitting

Timeline: Key moments in fight for gay rights

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

BioAge raises $170M for combination therapy with Zepbound

knowledge

knowledge

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

To avoid data mishandling cases, universities eye AI and other tools

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Reanimated hearts work just as well for transplants, study finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Robert F. Kennedy is pitching centrism on health, even on abortion

Drug repurposing or repositioning? The language matters

Medicare Advantage proposed rates disappoint insurers

Alkermes shareholders re

A disappointing year of Humira biosimilars

focus

Gilead might be held responsible for not developing a drug

Vaccine advisory panel ACIP left half staffed by HHS

Sea level rise could wash away turtle breeding grounds around the world, researchers say

A public health expert passes on football's full body collisions for youths

KalVista pill reduced swelling 'attacks' caused by genetic disease

Sea level rise could wash away turtle breeding grounds around the world, researchers say

focus

entertainment

leisure time

focus